Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,447 | 19,194 | 14,716 | 16,320 | 26,123 |
| Marketable Securities | N/A | 1,450 | 3,593 | 6,504 | N/A |
| TOTAL | $15,421 | $20,972 | $19,579 | $24,514 | $27,761 |
| Non-Current Assets | |||||
| PPE Net | 15 | 17 | 20 | 15 | 18 |
| Other Non-Current Assets | 174 | 180 | 176 | 170 | 64 |
| TOTAL | $189 | $197 | $196 | $185 | $82 |
| Total Assets | $15,610 | $21,169 | $19,775 | $24,699 | $27,843 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 670 | 1,571 | 1,304 | 1,003 | 1,098 |
| Accrued Expenses | 1,229 | 1,558 | 1,232 | 976 | 580 |
| Other current liabilities | N/A | N/A | 316 | N/A | N/A |
| TOTAL | $2,138 | $3,283 | $2,862 | $3,286 | $1,917 |
| Non-Current Liabilities | |||||
| TOTAL | $1 | $4 | $6 | $9 | $12 |
| Total Liabilities | $2,139 | $3,287 | $2,868 | $3,295 | $1,929 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,763 | 49,763 | 49,763 | 48,880 | 48,878 |
| Common Shares | 50 | 50 | 50 | 49 | 48 |
| Retained earnings | -140,400 | -135,522 | -130,072 | -123,901 | -118,336 |
| Other shareholders' equity | -101 | -101 | -6,102 | -6,129 | -6,102 |
| TOTAL | $13,471 | $17,882 | $16,907 | $21,404 | $25,914 |
| Total Liabilities And Equity | $15,610 | $21,169 | $19,775 | $24,699 | $27,843 |